Digital Papillary Adenocarcinoma

Also known as: Digital papillary adenocarcinoma (morphologic abnormality) / Aggressive digital papillary adenocarcinoma / Digital papillary carcinoma / Sweat gland adenocarcinoma (disorder) / Hidradenocarcinoma / Nodular hidradenoma, malignant (morphologic abnormality) / Sweat gland adenocarcinoma (morphologic abnormality)

Drug Trials

Drug	Drug Name	Drug Description

Drug	Drug Name	Target	Type

Drug	Drug Name	Phase	Status	Count
DB09035	Nivolumab	2	Active Not Recruiting	1
DB13896	Talimogene laherparepvec	2	Active Not Recruiting	1